Establishing a multi‐method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra‐performance liquid chromatography (UPLC)
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.6027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Sivaprasadu Ganta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GSS, GITAM (Deemed to be University), Visakhapatnam, India. Hauptthemen laut MEDLINE: Drug Contamination, Pyrazoles, Pyridones, Limit of Detection. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This groundbreaking study introduces a pioneering development of multi‐method approach for the first‐ever detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban (Apx) drug substance using ultra‐performance liquid chromatography (UPLC) with ultraviolet (UV) detector. In this novel endeavor, two distinct UPLC‐UV methods, Method A (for impurities A to G) and Method B (for impurities H to M), were meticulously developed and validated as per International Council for Harmonization (ICH) guidelines to address the challenge of identification and control of 13 GTIs in Apx drug substance. The validation process included rigorous assessment of linearity, accuracy, specificity, precision, limit of quantification (LOQ), and limit of detection (LOD) for each impurity in each method which marks a significant advancement in pharmaceutical analysis. The developed methods address the regulatory requirements set forth by ICH M7(R2) guidelines by providing a reliable approach for quantifying GTIs in Apx drug substance at trace levels to minimize the potential carcinogenic risk to the patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, GSS, GITAM (Deemed to be University), Visakhapatnam, India.
- Department of Chemistry, Sri GCSR Degree college, Rajam, A. P, India.
- Analytical Discovery Chemistry, Aragen Life Sciences Pvt. Ltd., IDA Nacharam, Hyderabad, India.
ORCID-Profile: Ravi Kumar Ganta
Zitieren
APA
Ganta, S., Pamerla, M., Gunupuru, S. K., Salakolusu, S., Bevara, S., Padhy, H., & Ganta, R. K. (2024). Establishing a multi‐method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra‐performance liquid chromatography (UPLC). Biomedical Chromatography. https://doi.org/10.1002/bmc.6027
Vancouver
Ganta S, Pamerla M, Gunupuru SK, Salakolusu S, Bevara S, Padhy H, et al. Establishing a multi‐method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra‐performance liquid chromatography (UPLC). Biomedical Chromatography. 2024. doi:10.1002/bmc.6027
BibTeX
@article{Ganta2024,
author = {Ganta, Sivaprasadu and Pamerla, Muralidhar and Gunupuru, Suresh Kumar and Salakolusu, Suresh and Bevara, Samatha and Padhy, Harihara and Ganta, Ravi Kumar},
title = {Establishing a multi‐method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra‐performance liquid chromatography (UPLC)},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.6027}
}
EUVIMED